These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
602 related items for PubMed ID: 21989726
1. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing. Ebihara N, Matsuda A, Nakamura S, Matsuda H, Murakami A. Invest Ophthalmol Vis Sci; 2011 Nov 01; 52(12):8549-57. PubMed ID: 21989726 [Abstract] [Full Text] [Related]
2. Anti-inflammatory effect of IL-6 receptor blockade in corneal alkali burn. Sakimoto T, Sugaya S, Ishimori A, Sawa M. Exp Eye Res; 2012 Apr 01; 97(1):98-104. PubMed ID: 22551515 [Abstract] [Full Text] [Related]
4. Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface. Sugaya S, Sakimoto T, Shoji J, Sawa M. Jpn J Ophthalmol; 2011 May 01; 55(3):277-282. PubMed ID: 21523377 [Abstract] [Full Text] [Related]
5. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model. Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, Scheller J, Rose-John S, Kado S, Takada T. J Immunol; 2010 Feb 01; 184(3):1543-51. PubMed ID: 20042582 [Abstract] [Full Text] [Related]
7. Enhancement of gingival inflammation induced by synergism of IL-1β and IL-6. Sawada S, Chosa N, Ishisaki A, Naruishi K. Biomed Res; 2013 Feb 01; 34(1):31-40. PubMed ID: 23428978 [Abstract] [Full Text] [Related]
8. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF. Nat Med; 2000 May 01; 6(5):583-8. PubMed ID: 10802717 [Abstract] [Full Text] [Related]
9. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells. Yang X, Lin A, Jiang N, Yan H, Ni Z, Qian J, Fang W. Nephrology (Carlton); 2017 Feb 01; 22(2):150-158. PubMed ID: 26869278 [Abstract] [Full Text] [Related]
10. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. Nakanishi H, Yoshioka K, Joyama S, Araki N, Myoui A, Ishiguro S, Ueda T, Yoshikawa H, Itoh K. Am J Pathol; 2004 Aug 01; 165(2):471-80. PubMed ID: 15277221 [Abstract] [Full Text] [Related]
11. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration. Okada Y, Saika S, Shirai K, Yamanaka O, Kitano A, Wang Z, Yang H, Reinach P. Ophthalmic Res; 2009 Aug 01; 42(4):185-92. PubMed ID: 19672126 [Abstract] [Full Text] [Related]
12. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Finotto S, Eigenbrod T, Karwot R, Boross I, Doganci A, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Galle PR, Neurath MF. Int Immunol; 2007 Jun 01; 19(6):685-93. PubMed ID: 17496315 [Abstract] [Full Text] [Related]
13. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel DT, Nishimoto N. Int J Cancer; 2006 Sep 15; 119(6):1303-11. PubMed ID: 16642474 [Abstract] [Full Text] [Related]
14. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3. Takizawa T, Yanagisawa M, Ochiai W, Yasukawa K, Ishiguro T, Nakashima K, Taga T. Cytokine; 2001 Mar 07; 13(5):272-9. PubMed ID: 11243705 [Abstract] [Full Text] [Related]
15. Interleukin-6 and its receptors: a highly regulated and dynamic system. Wolf J, Rose-John S, Garbers C. Cytokine; 2014 Nov 07; 70(1):11-20. PubMed ID: 24986424 [Abstract] [Full Text] [Related]
16. Early hepatocyte DNA synthetic response posthepatectomy is modulated by IL-6 trans-signaling and PI3K/AKT activation. Nechemia-Arbely Y, Shriki A, Denz U, Drucker C, Scheller J, Raub J, Pappo O, Rose-John S, Galun E, Axelrod JH. J Hepatol; 2011 May 07; 54(5):922-9. PubMed ID: 21145830 [Abstract] [Full Text] [Related]
17. Teleost IL-6 promotes antibody production through STAT3 signaling via IL-6R and gp130. Kaneda M, Odaka T, Suetake H, Tahara D, Miyadai T. Dev Comp Immunol; 2012 Oct 07; 38(2):224-31. PubMed ID: 22469658 [Abstract] [Full Text] [Related]
19. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture. Matsumiya T, Imaizumi T, Fujimoto K, Cui X, Shibata T, Tamo W, Kumagai M, Tanji K, Yoshida H, Kimura H, Satoh K. Exp Cell Res; 2001 Sep 10; 269(1):35-41. PubMed ID: 11525637 [Abstract] [Full Text] [Related]
20. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. Rose-John S, Scheller J, Elson G, Jones SA. J Leukoc Biol; 2006 Aug 10; 80(2):227-36. PubMed ID: 16707558 [Abstract] [Full Text] [Related] Page: [Next] [New Search]